Xultophy (insulin degludec/liraglutide)

pCPA File Number: 21164
Negotiation Status:
Active Negotiation
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CADTH Project Number:
SR0599-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable